(Q53432800)

14 May 2018

title

Effect of HMGCR variant alleles on low-density lipoprotein cholesterol-lowering response to atorvastatin in healthy Korean subjects. (English)

1 reference

14 May 2018

1 reference

Jae Yong Chung

1

1 reference

14 May 2018

Sung Kweon Cho

2

1 reference

14 May 2018

Eun Sil Oh

3

1 reference

14 May 2018

Dong Hwan Lee

4

1 reference

14 May 2018

Lay Ahyoung Lim

5

1 reference

14 May 2018

Seong Bok Jang

6

1 reference

14 May 2018

Yoon Jung Lee

7

1 reference

14 May 2018

Kyungsoo Park

8

1 reference

14 May 2018

Min Soo Park

9

1 reference

14 May 2018

publication date

22 March 2011

1 reference

14 May 2018

The Journal of Clinical Pharmacology

published in

1 reference

14 May 2018

volume

52

1 reference

14 May 2018

issue

3

1 reference

14 May 2018

page(s)

339-346

1 reference

14 May 2018

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Pharmacogenetic study of statin therapy and cholesterol reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Association of the functional variant in the 3-hydroxy-3-methylglutaryl-coenzyme a reductase gene with low-density lipoprotein-cholesterol in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Best-selling human medicines 2002-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Transporter pharmacogenetics and statin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

SLCO1B1 521T-->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011398239

21 January 2018

Identifiers

DOI

10.1177/0091270011398239

1 reference

14 May 2018

1 reference

14 May 2018